Governing the Scale-up of Longevity Medicine
Longevity science is moving from laboratory discovery toward clinical use through biomarkers, precision prevention, regenerative medicine, digital health and AI-enabled prediction. Translation into routine care remains uneven. The session explores evidence standards, regulation, clinical guidelines, reimbursement and workforce readiness while keeping care person-centred and equitable
Main Stage 2
10:30 am
- 11:30 am
